Intra-Cellular Therapies Inc.

Q3 2022 13F Holders

Symbol
ITCI
CUSIP
46116X101
Type
Equity
Class
COM
Num filers
278
Total reported value, excl. options
$3.89B
Manager Report Date Value ($000) Shares